biote (NASDAQ: BTMD) — Perfil da empresa, notícias e dados financeiros
Biote is a biopharmaceutical company specializing in hormone optimization and personalized healthcare solutions through BHRT.

biote
Biote (NASDAQ:BTMD) specializes in hormone optimization and personalized healthcare solutions, focusing on addressing hormonal imbalances through bio-identical hormone replacement therapy (BHRT). With a patient-centered approach, Biote aims to enhance the quality of life for individuals by offering tailored treatment plans that address a wide range of hormonal issues. Their projects extend into research and development of new protocols for hormone optimization, aiming to set new standards in personalized medicine. Biote's objectives are to expand its market reach, continuously improve patient outcomes through innovative therapies, and contribute to the broader understanding of hormone-related health conditions.
Resumo
Operações
Produtos e/ou serviços de biote
- Hormone optimization therapies, focusing on balancing hormones to improve patient health and wellbeing.
- Bioidentical hormone replacement therapy (BHRT) pellets, a natural approach to addressing hormone imbalances.
- Personalized hormone optimization plans, tailored to individual patient needs for comprehensive healthcare.
- Nutraceuticals line, offering supplements to support hormone health and overall wellness.
- Educational resources for practitioners, enhancing understanding of hormone optimization and BHRT.
- Partnership programs with healthcare providers, expanding access to hormone optimization treatments.
equipe executiva do biote
- Marc D. BeerExecutive Chairman
- Robert C. PetersonInterim CEO, CFO & Chief Business Officer
- John J. OlsenChief Information Officer
- Dan MonicoGeneral Counsel
- Richard Kevin KeyChief Digital Officer
- Jade BeutlerHead of Nutraceuticals
- Cory RiceChief Clinical Advisor & Member of Medical Advisory Board
- Joey LopesSVP of Strategy & Commercial Operations
- Komal BajajChief Medical Officer
Principais indicadores financeiros
Resultados divulgados pela biote , em USD.
- Cap. de mercado
- 40 mi
- Receita (TTM)
- 183,5 mi
- P/L
- 8.4
- LPA (diluído, TTM)
- 0.1
- Dividend yield
- —
- Margem de lucro
- 3.2%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 192,2 mi | 35,6 mi | 27 mi | |
| 197,2 mi | 31,6 mi | 3,2 mi | |
| 185,4 mi | 28,7 mi | 3,3 mi | |
| 165 mi | -60,7 mi | -969 mil |